Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
$0.00
$0.00
$0.00
$0.22
$15K-0.5743,518 shsN/A
Nemaura Medical Inc. stock logo
NMRD
Nemaura Medical
$0.00
-50.0%
$0.00
$0.00
$0.05
$4K0.58,341 shs400 shs
Sonendo, Inc. stock logo
SONX
Sonendo
$0.02
+98.2%
$1.09
$0.01
$17.00
$9K1.46981 shs636 shs
VRAYQ
ViewRay
$0.00
$0.00
$0.00
$18K1.05600 shs1,031 shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
0.00%0.00%-75.00%-98.71%-98.57%
Nemaura Medical Inc. stock logo
NMRD
Nemaura Medical
0.00%-50.00%0.00%0.00%-99.69%
Sonendo, Inc. stock logo
SONX
Sonendo
0.00%-98.09%-98.09%-98.07%-70.19%
VRAYQ
ViewRay
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
N/AN/AN/AN/AN/AN/AN/AN/A
Nemaura Medical Inc. stock logo
NMRD
Nemaura Medical
0.9049 of 5 stars
0.03.00.04.50.01.70.0
Sonendo, Inc. stock logo
SONX
Sonendo
N/AN/AN/AN/AN/AN/AN/AN/A
VRAYQ
ViewRay
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
0.00
N/AN/AN/A
Nemaura Medical Inc. stock logo
NMRD
Nemaura Medical
0.00
N/AN/AN/A
Sonendo, Inc. stock logo
SONX
Sonendo
0.00
N/AN/AN/A
VRAYQ
ViewRay
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
$7.16M0.00N/AN/A($0.03) per share-0.02
Nemaura Medical Inc. stock logo
NMRD
Nemaura Medical
$3.02K1.34N/AN/A($0.41) per share0.00
Sonendo, Inc. stock logo
SONX
Sonendo
$44.40M0.00N/AN/A$89.42 per share0.00
VRAYQ
ViewRay
$102.21M0.00N/AN/AN/ANaN
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
-$81.66MN/A0.00N/A-272.74%-311.64%-11.57%N/A
Nemaura Medical Inc. stock logo
NMRD
Nemaura Medical
-$14.14M-$0.39N/AN/AN/AN/AN/A9/29/2025 (Estimated)
Sonendo, Inc. stock logo
SONX
Sonendo
-$60.92M-$59.12N/AN/A-92.74%-184.01%-68.60%8/8/2025 (Estimated)
VRAYQ
ViewRay
-$107.33MN/A0.00N/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
N/AN/AN/AN/AN/A
Nemaura Medical Inc. stock logo
NMRD
Nemaura Medical
N/AN/AN/AN/AN/A
Sonendo, Inc. stock logo
SONX
Sonendo
N/AN/AN/AN/AN/A
VRAYQ
ViewRay
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
N/A
1.85
1.57
Nemaura Medical Inc. stock logo
NMRD
Nemaura Medical
N/AN/AN/A
Sonendo, Inc. stock logo
SONX
Sonendo
0.55
1.82
1.22
VRAYQ
ViewRay
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
56.91%
Nemaura Medical Inc. stock logo
NMRD
Nemaura Medical
4.41%
Sonendo, Inc. stock logo
SONX
Sonendo
28.68%
VRAYQ
ViewRay
15.47%

Insider Ownership

CompanyInsider Ownership
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
5.21%
Nemaura Medical Inc. stock logo
NMRD
Nemaura Medical
40.42%
Sonendo, Inc. stock logo
SONX
Sonendo
7.90%
VRAYQ
ViewRay
2.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
34029.78 million28.23 millionOptionable
Nemaura Medical Inc. stock logo
NMRD
Nemaura Medical
4040.35 million24.04 millionNo Data
Sonendo, Inc. stock logo
SONX
Sonendo
250429,000393,000Not Optionable
VRAYQ
ViewRay
300183.40 million178.82 millionNo Data

Recent News About These Companies

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Acutus Medical stock logo

Acutus Medical NASDAQ:AFIB

$0.0005 0.00 (0.00%)
As of 07/31/2025

Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

Nemaura Medical stock logo

Nemaura Medical NASDAQ:NMRD

$0.0001 0.00 (-50.00%)
As of 07/31/2025 09:46 AM Eastern

Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.

Sonendo stock logo

Sonendo NYSE:SONX

$0.02 +0.01 (+98.20%)
As of 07/30/2025 09:30 AM Eastern

Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. The company was incorporated in 2006 and is headquartered in Laguna Hills, California.

ViewRay NASDAQ:VRAYQ

ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, Italy, France, Taiwan, the United Kingdom, and internationally. It provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers through a network of direct sales force and distributors. ViewRay, Inc. was founded in 2004 and is headquartered in Denver, Colorado. On July 16, 2023, ViewRay, Inc., alongwith its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. On October 26, 2023, the voluntary petition of ViewRay , Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on July 16, 2023.